促胰液素增强MRCP在复发性急性胰腺炎患者中的价值
回顾性分析54例复发性急性胰腺炎患者及57例年龄性别匹配对照,评估促胰液素增强MRCP较常规MRCP的附加诊断价值。促胰液素增强图像显示患者外分泌功能减低比例显著高于对照组(32% vs 9%,p<0.01),且检测胰管异常的敏感度(76% vs 56%,p=0.01)和AUC(0.983 vs 0.760,p<0.01)均更高。作者认为促胰液素增强MRCP应纳入复发性急性胰腺炎患者的MRCP检查方案。
要点
- 复发性急性胰腺炎患者中约32%在促胰液素增强MRCP上显示外分泌功能减低,显著高于对照组的9%(p<0.01)。
- 促胰液素增强序列检测胰管异常的敏感度为76%,高于常规MRCP的56%(p=0.01)。
- 患者组侧支胰管扩张的比值比为3.6(p=0.02),胰腺分裂未见显著差异。
核心结论
- 促胰液素增强MRCP对复发性急性胰腺炎患者胰管异常的检出率显著高于常规MRI,应作为该类患者MRCP检查方案的一部分。
研究设计与样本
- 回顾性研究,纳入54例复发性急性胰腺炎患者(无胰腺肿瘤或手术史,且于急性胰腺炎发作3个月以上行MRI)及57例年龄和性别匹配的对照者,所有病例均有促胰液素增强MRCP与ERCP结果对照且间隔在3个月内,时间范围为2007年1月至2011年12月。
诊断标准与关键数值
- 以ERCP为参考标准,促胰液素增强MRCP检测胰管异常的敏感度为76%,常规MRCP为56%(p=0.01);AUC分别为0.983和0.760(p<0.01)。
临床应用与阅片要点
- 作者认为促胰液素增强MRCP应作为复发性急性胰腺炎患者MRCP检查方案的一部分;阅片时需评估促胰液素增强后的外分泌反应及胰管异常。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to assess the additional value of secretin-enhanced MRCP over conventional (non-secretin-enhanced) MRCP in diagnosing disease in patients with recurrent acute pancreatitis.
MATERIALS AND METHODS: A retrospective review of a radiology database found 72 patients with recurrent acute pancreatitis who had secretin-enhanced MRCP and ERCP correlation within 3 months of each other between January 2007 and December 2011. Of these patients, 54 had no history of pancreatic tumor or surgery and underwent MRI more than 3 months after an episode of acute pancreatitis. In addition, 57 age- and sex-matched control subjects with secretin-enhanced MRCP and ERCP correlation and without a diagnosis of recurrent acute pancreatitis or chronic pancreatitis were enrolled as the control group. All studies were anonymized, and secretin-enhanced MRCP images (image set A) were separated from conventional 2D and 3D MRCP and T2-weighted images (image set B). Image sets A and B for each patient were assigned different and randomized case numbers. Two blinded reviewers independently assessed both image sets for ductal abnormalities and group A image sets for exocrine response to secretin.
RESULTS: There were statistically significantly more patients with recurrent acute pancreatitis with reduced exocrine function compared with patients in the control group (32% vs 9%; p < 0.01) on secretin-enhanced images. Patients with recurrent acute pancreatitis were more likely to have side branch dilation (p = 0.02; odds ratio, 3.6), but not divisum, compared with the control group. Secretin-enhanced images were superior to non-secretin-enhanced images for detecting ductal abnormalities in patients with recurrent acute pancreatitis, with higher sensitivity (76% vs 56%; p = 0.01) and AUC values (0.983 vs 0.760; p < 0.01).
CONCLUSION: Up to one-third of patients with recurrent acute pancreatitis showed exocrine functional abnormalities. Secretin-enhanced MRCP had a significantly higher yield for ductal abnormalities than did conventional MRI and should be part of the MRCP protocol for investigation of patients with recurrent acute pancreatitis.
引用
- Sandrasegaran K, Tahir B, Barad U, et al. The Value of Secretin-Enhanced MRCP in Patients With Recurrent Acute Pancreatitis. AJR Am J Roentgenol. 2016. PMID: 27824485. doi:10.2214/AJR.16.16566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。